Scibase AB (SCIB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.516x

Based on the latest financial reports, Scibase AB (SCIB) has a cash flow conversion efficiency ratio of -0.516x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.29 Million ≈ $-1.86 Million USD) by net assets (Skr33.48 Million ≈ $3.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Scibase AB - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Scibase AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Scibase AB for a breakdown of total debt and financial obligations.

Scibase AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Scibase AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ihlas Yayin Holding A.S.
IS:IHYAY
0.011x
Southern Energy Corp
V:SOU
0.062x
Bakkavor Group PLC
LSE:BAKK
0.094x
Cliq Digital AG
F:CLIQ
0.212x
RLF Agtech Ltd
AU:RLF
-0.192x
Volt Resources Ltd
AU:VRC
-0.029x
Trigon Metals Inc
V:TM
0.195x
Sub Sri Thai Public Company Limited
BK:SST
0.048x

Annual Cash Flow Conversion Efficiency for Scibase AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of Scibase AB from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Scibase AB market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr36.65 Million
≈ $3.94 Million
Skr-57.38 Million
≈ $-6.18 Million
-1.566x -29.68%
2023-12-31 Skr43.06 Million
≈ $4.63 Million
Skr-51.98 Million
≈ $-5.59 Million
-1.207x +31.48%
2022-12-31 Skr25.24 Million
≈ $2.72 Million
Skr-44.47 Million
≈ $-4.79 Million
-1.762x -215.78%
2021-12-31 Skr70.80 Million
≈ $7.62 Million
Skr-39.50 Million
≈ $-4.25 Million
-0.558x +22.78%
2020-12-31 Skr46.86 Million
≈ $5.04 Million
Skr-33.86 Million
≈ $-3.64 Million
-0.723x +39.05%
2019-12-31 Skr32.01 Million
≈ $3.45 Million
Skr-37.96 Million
≈ $-4.08 Million
-1.186x -126.10%
2018-12-31 Skr71.48 Million
≈ $7.69 Million
Skr-37.48 Million
≈ $-4.03 Million
-0.524x -37.36%
2017-12-31 Skr115.72 Million
≈ $12.45 Million
Skr-44.18 Million
≈ $-4.75 Million
-0.382x -47.93%
2016-12-31 Skr185.41 Million
≈ $19.95 Million
Skr-47.85 Million
≈ $-5.15 Million
-0.258x -61.43%
2015-12-31 Skr291.42 Million
≈ $31.36 Million
Skr-46.59 Million
≈ $-5.01 Million
-0.160x +85.92%
2014-12-31 Skr32.65 Million
≈ $3.51 Million
Skr-37.08 Million
≈ $-3.99 Million
-1.136x -20.76%
2013-12-31 Skr36.18 Million
≈ $3.89 Million
Skr-34.03 Million
≈ $-3.66 Million
-0.940x -161.14%
2012-12-31 Skr-23.69 Million
≈ $-2.55 Million
Skr-36.44 Million
≈ $-3.92 Million
1.538x --

About Scibase AB

ST:SCIB Sweden Medical Devices
Market Cap
$18.23 Million
Skr169.40 Million SEK
Market Cap Rank
#25316 Global
#519 in Sweden
Share Price
Skr0.41
Change (1 day)
+0.00%
52-Week Range
Skr0.21 - Skr0.43
All Time High
Skr33.21
About

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more